Role of caval venous manipulation in treatment of protein-losing enteropathy

Cardiology in the Young

Volumn 18, Issue 3, 2008, Pages 275-281

  Menon, Shaji ^a   Hagler, Donald ^a   Cetta, Frank ^a   Gloviczki, Peter ^a   Driscoll, David ^a  

^a MAYO CLINIC   (United States)

Author keywords

Caval venous obstruction; Caval venous stenting; Spiral venous graft; Thoracic duct

Indexed keywords

ALBUMIN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; STEROID; STREPTOKINASE;

ADOLESCENT; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CASE REPORT; CAVA VEIN OBSTRUCTION; CHILD; CHYLOTHORAX; DRUG DOSE INCREASE; FALLOT TETRALOGY; FEMALE; FONTAN PROCEDURE; FOOT EDEMA; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; HYPOCALCEMIA; HYPOKALEMIA; INFERIOR CAVA VEIN OBSTRUCTION; INTESTINE BIOPSY; LABORATORY TEST; LEIOMYOMA; LIPID DIET; LYMPHATIC SYSTEM DISEASE; MALE; MEDIASTINUM TUMOR; PERICARDIAL EFFUSION; PROTEIN DIET; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY ARTERY STENOSIS; PULMONARY VALVE ATRESIA; SUPERIOR CAVA VEIN OBSTRUCTION; SUPERIOR CAVA VEIN SYNDROME; TRICUSPID VALVE REGURGITATION; VEIN BLOOD FLOW;

CHILD; CHILD, PRESCHOOL; DILATATION, PATHOLOGIC; FEMALE; FONTAN PROCEDURE; HEART DISEASES; HUMANS; LYMPHATIC VESSELS; MALE; PROTEIN-LOSING ENTEROPATHIES; SUPERIOR VENA CAVA SYNDROME;

EID: 44649146448     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951108001996     Document Type: Article

References (19)

1. Drake RE, Anwar Z, Kee S, Gabel JC. Intestinal lymphatic pressure increases during intravenous infusions in awake sheep. Am J Physiol 1993; 265: R703-705.
2. Wegria R, Zekert H, Walter KE, et al. Effect of systemic venous pressure on drainage of lymph from thoracic duct. Am J Physiol 1963; 204: 284-288.
3. Marshall Jr WH, Neyazaki T, Abrams HL. Abnormal protein loss after thoracic-duct ligation in dogs. N Engl J Med 1965; 273: 1092-1094.
4. Blalock A, Cunningham RS, Robinson CS. Experimental production of chylothorax by occlusion of the superior vena cava. Ann Surg 1936; 104: 359-364.
5. Molnar Z, Karoliny G, Mozsik G, Nemeth A. Lymphogenic enteropathy from thoracic duct obstruction. Lymphology 1974; 7: 130-136.
6. Neyazaki T, Kupic E, Marshall W, Abrams H. Collateral lymphatico-venous communications after experimental obstruction of the thoracic duct. Radiology 1965; 85: 423-432.
7. Kondo M, Nakanishi K, Bamba T, Hosokawa K, Masuda M. Experimental protein-losing gastroenteropathy, role of tissue plasminogen activator. Gastroenterology 1976; 71: 631-634.
8. Blalock A, Robinson C, Cunningham R, Gray M. Experimental studies in lymphatic blockage. Arch Surg 1937; 34: 1049-1071.
9. Feldt RH, Driscoll DJ, Offord KP, et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 1996; 112: 672-680.
10. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein losing enteropathy after the Fontan operation: An international multicenter study. J Thorac Cardiovasc Surg 1998; 115: 1063-1073.
11. Mair DD, Puga FJ, Danielson GK. Late functional status of survivors of the Fontan procedure performed during the 1970s. Circulation 1992; 86: II106-II109.
12. Ostrow AM, Freeze H, Rychik J. Protein losing enteropathy after Fontan operation: Investigation into possible pathophysiologic mechanisms. Ann Thorac Surg 2006; 82: 695-701.
13. Gleason Jr WA, Roodman ST, Laks H. Protein-losing enteropathy and intestinal lymphangiectasia after superior vena cava-right pulmonary artery (Glenn) shunt. J Thorac Cardiovasc Surg 1979; 77:843-846.
14. Ludwig C, Tomsa W. Die Anfänge der Lymphgefässe im Hoden. Sitzungsberichte der Mathematisch-Naturwissenschaftlichen Classe der Kaiserlichen Akademie der Wissenschaften 1861; 44: 155-156.
15. Dousset B, Legmann P, Soubrane O, et al. Protein-losing enteropathy secondary to hepatic venous outflow obstruction after liver transplantation. J Hepatol 1997; 27: 206-210.
16. Rychik J, Gui-Yang S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am J Cardiol 2002; 90: 672-674.
17. Ohhashi T, Watanabe N, Kawai Y. Effects of atrial natriuretic peptide on isolated bovine mesenteric lymph vessels. Am J Physiol 1990; 259 (1 Pt 2): H42-47.
18. Atchison DJ, Johnston MG. Atrial natriuretic peptide attenuates flow in an isolated lymph duct preparation. Eur J Physiol 1996; 431: 618-624.
19. Rychik J, Piccoli D, Barber G. Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am J Cardiol 1991; 68: 819-821.